Pharmafile Logo

Fleet Laboratories

Fleet Laboratories Ltd are part of the DDD Group of Companies which was established in 1912 and is still privately owned. We work with customers in the health and beauty industry manufacturing pharmaceutical products on behalf of the licence holder and developing and manufacturing toiletry products for both brand owners and retailers. We have a diverse range of customers, some of whom we have worked with for nearly 30 years. Depending on your business need, we have a flexible range of services available.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

94 Rickmansworth Road, Watford, Herts, WD18 7JJ, United Kingdom
+44 (0)1923 229251

 Latest Content from PMHub 

5 ways to engage HCPs in medical education

White Papers and Resources | February 16, 2024 | Wiley

How to bring credibility, trust and flexibility into your medical education programs

Navigating challenges of MedTech research with rare-disease patients

White Papers and Resources | February 16, 2024 | Inizio

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series

Press Releases | February 15, 2024 | Medscape Education

What are some of the biggest gaps that women face in healthcare today?  “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....

Have you heard from her?

Press Releases | February 15, 2024 | Medscape Education

We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...

Clinical trial considerations: Why diversity matters…

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Press Releases | February 14, 2024 | Petauri Evidence

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.

The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...

Product launch: What market research when?

White Papers and Resources | February 14, 2024 | Inizio

Get the insights you need, when you need them, for your product launch planning

Clinical trial considerations: Why digital matters…

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.